Breast lumps are very common, but not all lumps require treatment. The doctor’s decision to treat a lump is based on the clinical examination and imaging findings. In 1992, the American College of Radiology (ACR) created and recommended the Breast Imaging Reporting and Data System (BIRADS), which has become the diagnostic standard for mammography, ultrasound and MRI. It has become the diagnostic standard for mammography, ultrasound and MRI. The criteria are as follows: Grade I is negative and follow-up is recommended; Grade II is considered benign and regular follow-up is recommended (e.g., once a year); Grade III is likely to be benign (about 2% malignant) but requires shorter follow-up intervals (e.g., once every 3-6 months); Grade IV is likely to be malignant and biopsy is recommended; Grade V is highly suspicious of malignant lesions (greater than 95% malignant) and requires surgical biopsy and appropriate management. The biopsy should be removed and treated appropriately. Therefore, surgical biopsy is only considered for patients with BIRADS grade IV and V clinical breast imaging, while patients with grade III need to be closely monitored. There is no large sample of trials to confirm that Chinese medicine can eliminate breast lumps. Therefore, herbal medicine can only be used as an adjuvant treatment. When a breast lump cannot be ruled out as malignant, an early surgical biopsy should be performed to avoid delaying treatment.